Table 2.
MAM/variable | Df | F | P |
---|---|---|---|
Log2R(IL1B) ~ treatment | 1/46 | 17.88 | <0.001 |
Log2R(IL6) ~ treatment + DPI | 3/44 | 5.63 | 0.002 |
Treatment | 1/44 | 6.70 | 0.013 |
DPI | 2/44 | 5.09 | 0.010 |
Log2R(IL10) ~ treatment + DPI | 3/44 | 8.50 | <0.001 |
Treatment | 1/44 | 9.33 | 0.004 |
DPI | 2/44 | 8.09 | 0.001 |
Log2R(CXCLi2) ~ treatment + DPI | 3/44 | 12.41 | =0.001 |
Treatment | 1/44 | 16.21 | <0.001 |
DPI | 2/44 | 10.51 | <0.001 |
Log2R(TNFSF15) ~ treatment + DPI | 5/42 | 4.55 | 0.002 |
Treatment | 3/42 | 6.87 | 0.001 |
DPI | 4/42 | 2.35 | 0.070 |
Treatment: DPI | 2/42 | 3.63 | 0.035 |
Based on the relative expression ratio (R) data (i.e., 28S rRNA- and control-normalized relative expression quantities).
Treatment, inoculation with VA1994 or NC2006; DPI, days postinoculation; IL, interleukin; TNFSF, tumor necrosis factor superfamily members.